MAIA Biotechnology, Inc. Announces the Appointment of Steven M. Chaouki to Its Board of Directors

Steven Spielberg

CHICAGO, September 28, 2021–(BUSINESS WIRE)–MAIA Biotechnology, Inc., a targeted therapy, immuno-oncology company focused on developing potential first-in-class oncology drugs (“MAIA”), announced today that it has appointed Steven M. Chaouki to its Board of Directors. Mr. Chaouki is a finance executive with over two decades of experience across capital markets and […]

Subscribe US Now